Ingevity Corp (NGVT)

Name: Ingevity Corp (NGVT) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001653477 · NYSE · Chemicals & Allied Products

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Ingevity Corp reported revenue of $1.17B. Revenue fell 2.7% from the prior annual period.

Key ratios (year ended 2025-12-31)

39.5%

Gross margin

35.9%

Operating margin

-14.3%

Net margin

-562.6%

Return on year-end equity

-2.7%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	n/a	$1.17B	$1.20B	$1.22B	$1.67B	$1.39B	$1.22B	$1.29B	$1.13B	$972.40M	$908.30M
Cost of Revenue	n/a	$706.10M	$735.30M	$770.50M	$1.10B	$878.70M	$750.60M	$810.90M	$716.80M	$643.40M	$633.90M
Gross Profit	n/a	$461.50M	$464.80M	$445.00M	$570.10M	$512.80M	$465.50M	$482.00M	$416.80M	$329.00M	$274.40M
R&D Expense	n/a	$28.40M	$24.50M	$25.40M	$30.30M	$26.30M	$22.60M	$19.70M	$21.50M	$19.80M	$17.60M
Operating Income	n/a	$418.70M	$425.90M	$423.20M	$452.60M	$422.20M	$397.90M	$396.90M	$320.50M	$242.70M	$163.60M
Depreciation & Amortization	$100.60M	$106.40M	$108.30M	$122.80M	$108.80M	$109.90M	$100.20M	$85.00M	$57.00M	$40.40M	$38.80M
EBITDA	n/a	$525.10M	$534.20M	$546.00M	$561.40M	$532.10M	$498.10M	$481.90M	$377.50M	$283.10M	$202.40M
Net Income	$54.00M	-$167.10M	-$430.30M	-$5.40M	$211.60M	$118.10M	$181.40M	$183.70M	$169.10M	$126.50M	$35.20M
EPS (Diluted)	n/a	-$4.61	-$11.85	-$0.15	$5.50	$2.95	$4.37	$4.35	$3.97	$2.97	$0.83
Total Assets	$1.54B	$1.65B	$2.02B	$2.62B	$2.74B	$2.47B	$2.33B	$2.14B	$1.32B	$929.60M	$832.80M
Total Liabilities	$1.49B	$1.62B	$1.83B	$1.99B	$2.04B	$1.80B	$1.69B	$1.61B	$976.50M	$651.70M	$698.20M
Shareholders' Equity	$46.90M	$29.70M	$195.20M	$631.40M	$698.30M	$673.80M	n/a	n/a	$338.70M	$263.90M	$127.00M
Cash & Equivalents	$97.40M	$78.10M	$68.00M	$95.90M	$76.70M	$275.40M	$257.70M	$56.50M	$77.50M	$87.90M	$30.50M
Operating Cash Flow	$211.00M	$331.20M	$128.60M	$205.10M	$313.40M	$293.30M	$352.40M	$275.70M	$252.00M	$174.30M	$127.90M
Capital Expenditures	$56.10M	$57.70M	$77.60M	$109.80M	$142.50M	$103.80M	$82.10M	$114.80M	$93.90M	$52.60M	$56.70M
Free Cash Flow	$154.90M	$273.50M	$51.00M	$95.30M	$170.90M	$189.50M	$270.30M	$160.90M	$158.10M	$121.70M	$71.20M
Share Repurchases	$143.10M	$56.30M	$0	$92.10M	$145.20M	$109.40M	$88.00M	$6.40M	$47.40M	$6.60M	$0
Shares Outstanding	34.48M	35.49M	36.35M	36.23M	37.30M	39.27M	40.51M	41.83M	41.69M	42.09M	42.12M
Weighted Average Diluted Shares	n/a	36.22M	36.32M	36.71M	38.47M	40.06M	41.55M	42.20M	42.60M	42.53M	42.27M
EPS (Basic)	n/a	-$4.61	-$11.85	-$0.15	$5.54	$2.97	$4.39	$4.39	$4.02	$3.00	$0.83

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView